Your browser doesn't support javascript.
loading
Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma.
Shirasawa, Masayuki; Yoshida, Tatsuya; Takayanagi, Daisuke; Shiraishi, Kouya; Yagishita, Shigehiro; Sekine, Katsutoshi; Kanda, Shintaro; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Hamada, Akinobu; Kohno, Takashi; Yamamoto, Noboru; Watanabe, Shun-Ichi; Ohe, Yuichiro; Motoi, Noriko.
Afiliación
  • Shirasawa M; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan. Electronic address: tatyoshi@ncc.go.jp.
  • Takayanagi D; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Yagishita S; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan.
  • Sekine K; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Internal Medicine, Saitama City Hospital, Saitama, Japan.
  • Kanda S; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Matsumoto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Masuda K; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Shinno Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Okuma Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Hamada A; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan.
  • Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Yamamoto N; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Watanabe SI; Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Motoi N; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Clin Lung Cancer ; 22(4): 282-291.e6, 2021 07.
Article en En | MEDLINE | ID: mdl-33722498
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Neuroendocrino / Carcinoma de Células Grandes / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Neuroendocrino / Carcinoma de Células Grandes / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos